about
5. IgE, mast cells, basophils, and eosinophilsInterferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo.IgE, mast cells, basophils, and eosinophils.Eosinophilic gastroenteritis and related eosinophilic disordersEffect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders.CD2 identifies a monocyte subpopulation with immunoglobulin E-dependent, high-level expression of Fc epsilon RIT(H)2 heterogeneity: Does function follow form?Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells.Novel targeted therapies for eosinophilic disordersImmunomodulatory therapy of eosinophil-associated gastrointestinal diseases.The retinoic acid receptor-α modulators ATRA and Ro415253 reciprocally regulate human IL-5+ Th2 cell proliferation and cytokine expression.Rapamycin preferentially inhibits human IL-5+ TH2-cell proliferation via an mTORC1/S6 kinase-1-dependent pathway.Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome.Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils.Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti–IL-5 antibody SCH55700Vaccine requirements for sustained cellular immunity to an intracellular parasitic infectionAbnormal differentiation of memory T cells in systemic lupus erythematosusDexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes
P50
Q28295231-3815842E-D475-4803-BC9D-A60C04A5CC37Q33419694-155D6E55-12B1-43FA-948D-C34E1FF3AE37Q33760398-3E3A4DBC-C54C-43D0-BE1F-2A4A6C35A837Q34035270-6BE2FCAC-3252-4BD4-8D8F-8B0816B918AEQ34993078-F7710316-088F-46C1-ACDA-9271F28BD873Q35167144-707B9735-441F-45B4-8F8A-DF59D77DC017Q36109798-E6BA3C35-A958-4FEF-AEBD-6FBA6C280C76Q36243111-BE33C1D9-9EEF-48E6-BBB9-988DDB036F33Q36763565-A2E86BFE-EACE-44D2-8C8D-66C5AA02476EQ37336072-6D6EF529-A8A1-48F7-80FF-9403A68677B9Q37441738-3EB1FA13-8615-4819-A580-A18E595D1160Q40421453-31C38434-ED7C-4A43-9316-47C8A8EF3DDBQ43218742-2735BE1F-1B54-4D16-8AAE-73ACFB9E5CAAQ43884515-CCBEEE41-BAD0-490E-8097-A69952816EEBQ44729936-6BD3F36F-CA35-45CA-A4A8-8244273F67EAQ48021818-A4CDC87B-161E-4648-AF44-6B1CAE6338CAQ59291567-85B035BB-432C-4F9A-A5AD-A17801B38B21Q77658710-A03F82BA-403E-4FAA-BBA6-91D1CC6E294AQ79794971-9AFA0B63-020B-46CE-B460-28BDC1278CE4Q88608121-C0914F55-FD3C-4C3B-B233-27785630074A
P50
description
researcher ORCID ID = 0000-0002-3917-3326
@en
wetenschapper
@nl
name
Calman Prussin
@ast
Calman Prussin
@en
Calman Prussin
@es
Calman Prussin
@nl
type
label
Calman Prussin
@ast
Calman Prussin
@en
Calman Prussin
@es
Calman Prussin
@nl
prefLabel
Calman Prussin
@ast
Calman Prussin
@en
Calman Prussin
@es
Calman Prussin
@nl
P1153
6701413687
P31
P496
0000-0002-3917-3326